The most widely available 18F-based PSMA agent is [18F]18F-DCFPyL, a clinically validated, FDA-approved tracer that is highly sensitive for prostate cancer staging and recurrence detection (PSA levels ≥ 0.2 ng/mL). This evidence concerns the gene FOLH1 and prostate cancer.